Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs

Combination antiretroviral therapy (cART) administered shortly after human immunodeficiency virus type 1 (HIV-1) infection can suppress viremia and limit seeding of the viral reservoir, but lifelong treatment is required for the majority of patients. Highly potent broadly neutralizing HIV-1 monoclon...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Virol
मुख्य लेखकों: Bolton, Diane L., Pegu, Amarendra, Wang, Keyun, McGinnis, Kathleen, Nason, Martha, Foulds, Kathryn, Letukas, Valerie, Schmidt, Stephen D., Chen, Xuejun, Todd, John Paul, Lifson, Jeffrey D., Rao, Srinivas, Michael, Nelson L., Robb, Merlin L., Mascola, John R., Koup, Richard A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society for Microbiology 2016
विषय:
Vaccines and Antiviral Agents
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4719604/
https://ncbi.nlm.nih.gov/pubmed/26581981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02454-15
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन